Silymarin Extends Lifespan and Reduces Proteotoxicity in C. elegans Alzheimer’s Model

E-ISSN： 1996-3181|14|2|295-302

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.14, Iss.2, 2015-03, pp. : 295-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Iridoid Compound 10-O-trans-p-Coumaroylcatalpol Extends Longevity and Reduces Alpha Synuclein Aggregation in Caenorhabditis elegans

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-12 ,pp. : 984-992

Bentham Science Publishers

Access to resources Recommend Favorite

Transgenic animal model for Alzheimer’s disease

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 6, 1998-06 ,pp. : 729-732

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy in a Rabbit Model of Alzheimer’s Disease

By S. Woodruff-Pak Diana Shriver Christina Agelan Alexis M. Manns Joanne Coico Richard

Drug Delivery Letters, Vol. 2, Iss. 1, 2012-03 ,pp. : 14-21

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer’s Disease

Current Medicinal Chemistry, Vol. 23, Iss. 24, 2016-07 ,pp. : 2770-2788

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s Disease

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite